Emelie Berglund new Chief Technology Officer at Prostatype Genomics
After building up the company's commercial organization, Prostatype Genomics is now also strengthening the scientific activities by hiring Emelie Berglund as the new Chief Technology Officer/Medical Affairs.On November 8, Emelie will take over the important role of CTO of Prostatype Genomics from Lidi Xu, who has held the position since 2019. Lidi is leaving the company to move back to China with her family but will continue to work on various projects for Prostatype Genomics. Emelie Berglund has a PhD in Biotechnology from the Royal Institute of Technology in Stockholm, and more than